Global and China Microbiome Drugs Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Probiotics
1.2.3 Prebiotics
1.2.4 Small Molecules
1.2.5 Biological Drugs
1.2.6 Other
1.3 Market by Application
1.3.1 Global Microbiome Drugs Market Share by Application: 2020 VS 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Microbiome Drugs Market Perspective (2015-2026)
2.2 Global Microbiome Drugs Growth Trends by Regions
2.2.1 Microbiome Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Microbiome Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Microbiome Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiome Drugs Players by Market Size
3.1.1 Global Top Microbiome Drugs Players by Revenue (2015-2020)
3.1.2 Global Microbiome Drugs Revenue Market Share by Players (2015-2020)
3.2 Global Microbiome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Microbiome Drugs Revenue
3.4 Global Microbiome Drugs Market Concentration Ratio
3.4.1 Global Microbiome Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Drugs Revenue in 2019
3.5 Key Players Microbiome Drugs Area Served
3.6 Key Players Microbiome Drugs Product Solution and Service
3.7 Date of Enter into Microbiome Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Drugs Breakdown Data by Type (2015-2026)
4.1 Global Microbiome Drugs Historic Market Size by Type (2015-2020)
4.2 Global Microbiome Drugs Forecasted Market Size by Type (2021-2026)
5 Microbiome Drugs Breakdown Data by Application (2015-2026)
5.1 Global Microbiome Drugs Historic Market Size by Application (2015-2020)
5.2 Global Microbiome Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Microbiome Drugs Market Size (2015-2026)
6.2 North America Microbiome Drugs Market Size by Type (2015-2020)
6.3 North America Microbiome Drugs Market Size by Application (2015-2020)
6.4 North America Microbiome Drugs Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Microbiome Drugs Market Size (2015-2026)
7.2 Europe Microbiome Drugs Market Size by Type (2015-2020)
7.3 Europe Microbiome Drugs Market Size by Application (2015-2020)
7.4 Europe Microbiome Drugs Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Microbiome Drugs Market Size (2015-2026)
8.2 China Microbiome Drugs Market Size by Type (2015-2020)
8.3 China Microbiome Drugs Market Size by Application (2015-2020)
8.4 China Microbiome Drugs Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Microbiome Drugs Market Size (2015-2026)
9.2 Japan Microbiome Drugs Market Size by Type (2015-2020)
9.3 Japan Microbiome Drugs Market Size by Application (2015-2020)
9.4 Japan Microbiome Drugs Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Microbiome Drugs Market Size (2015-2026)
10.2 Southeast Asia Microbiome Drugs Market Size by Type (2015-2020)
10.3 Southeast Asia Microbiome Drugs Market Size by Application (2015-2020)
10.4 Southeast Asia Microbiome Drugs Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Microbiome Drugs Introduction
11.1.4 Pfizer Revenue in Microbiome Drugs Business (2015-2020))
11.1.5 Pfizer Recent Development
11.2 Second Genome
11.2.1 Second Genome Company Details
11.2.2 Second Genome Business Overview
11.2.3 Second Genome Microbiome Drugs Introduction
11.2.4 Second Genome Revenue in Microbiome Drugs Business (2015-2020)
11.2.5 Second Genome Recent Development
11.3 Seres Therapeutics
11.3.1 Seres Therapeutics Company Details
11.3.2 Seres Therapeutics Business Overview
11.3.3 Seres Therapeutics Microbiome Drugs Introduction
11.3.4 Seres Therapeutics Revenue in Microbiome Drugs Business (2015-2020)
11.3.5 Seres Therapeutics Recent Development
11.4 MaaT Pharma
11.4.1 MaaT Pharma Company Details
11.4.2 MaaT Pharma Business Overview
11.4.3 MaaT Pharma Microbiome Drugs Introduction
11.4.4 MaaT Pharma Revenue in Microbiome Drugs Business (2015-2020)
11.4.5 MaaT Pharma Recent Development
11.5 Enterome Bioscience
11.5.1 Enterome Bioscience Company Details
11.5.2 Enterome Bioscience Business Overview
11.5.3 Enterome Bioscience Microbiome Drugs Introduction
11.5.4 Enterome Bioscience Revenue in Microbiome Drugs Business (2015-2020)
11.5.5 Enterome Bioscience Recent Development
11.6 MicroBiome Therapeutics
11.6.1 MicroBiome Therapeutics Company Details
11.6.2 MicroBiome Therapeutics Business Overview
11.6.3 MicroBiome Therapeutics Microbiome Drugs Introduction
11.6.4 MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2015-2020)
11.6.5 MicroBiome Therapeutics Recent Development
11.7 Ritter Pharmaceuticals
11.7.1 Ritter Pharmaceuticals Company Details
11.7.2 Ritter Pharmaceuticals Business Overview
11.7.3 Ritter Pharmaceuticals Microbiome Drugs Introduction
11.7.4 Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2015-2020)
11.7.5 Ritter Pharmaceuticals Recent Development
11.8 Rebiotix
11.8.1 Rebiotix Company Details
11.8.2 Rebiotix Business Overview
11.8.3 Rebiotix Microbiome Drugs Introduction
11.8.4 Rebiotix Revenue in Microbiome Drugs Business (2015-2020)
11.8.5 Rebiotix Recent Development
11.9 OpenBiome
11.9.1 OpenBiome Company Details
11.9.2 OpenBiome Business Overview
11.9.3 OpenBiome Microbiome Drugs Introduction
11.9.4 OpenBiome Revenue in Microbiome Drugs Business (2015-2020)
11.9.5 OpenBiome Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Microbiome Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Probiotics
Table 4. Key Players of Prebiotics
Table 5. Key Players of Small Molecules
Table 6. Key Players of Biological Drugs
Table 7. Key Players of Other
Table 8. Global Microbiome Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Microbiome Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Microbiome Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Microbiome Drugs Market Share by Regions (2015-2020)
Table 12. Global Microbiome Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Microbiome Drugs Market Share by Regions (2021-2026)
Table 14. Microbiome Drugs Market Market Trends
Table 15. Microbiome Drugs Market Drivers
Table 16. Microbiome Drugs Market Challenges
Table 17. Microbiome Drugs Market Restraints
Table 18. Global Microbiome Drugs Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Microbiome Drugs Market Share by Players (2015-2020)
Table 20. Global Top Microbiome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Drugs as of 2019)
Table 21. Global Microbiome Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Microbiome Drugs Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Microbiome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Microbiome Drugs Market Size Share by Type (2015-2020)
Table 27. Global Microbiome Drugs Revenue Market Share by Type (2021-2026)
Table 28. Global Microbiome Drugs Market Size Share by Application (2015-2020)
Table 29. Global Microbiome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Microbiome Drugs Market Size Share by Application (2021-2026)
Table 31. North America Microbiome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Microbiome Drugs Market Share by Type (2015-2020)
Table 33. North America Microbiome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Microbiome Drugs Market Share by Application (2015-2020)
Table 35. North America Microbiome Drugs Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Microbiome Drugs Market Share by Country (2015-2020)
Table 37. Europe Microbiome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Microbiome Drugs Market Share by Type (2015-2020)
Table 39. Europe Microbiome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Microbiome Drugs Market Share by Application (2015-2020)
Table 41. Europe Microbiome Drugs Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Microbiome Drugs Market Share by Country (2015-2020)
Table 43. China Microbiome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 44. China Microbiome Drugs Market Share by Type (2015-2020)
Table 45. China Microbiome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 46. China Microbiome Drugs Market Share by Application (2015-2020)
Table 47. China Microbiome Drugs Market Size by Region (US$ Million) (2015-2020)
Table 48. China Microbiome Drugs Market Share by Region (2015-2020)
Table 49. Japan Microbiome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Microbiome Drugs Market Share by Type (2015-2020)
Table 51. Japan Microbiome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Microbiome Drugs Market Share by Application (2015-2020)
Table 53. Japan Microbiome Drugs Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Microbiome Drugs Market Share by Country (2015-2020)
Table 55. Southeast Asia Microbiome Drugs Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Microbiome Drugs Market Share by Type (2015-2020)
Table 57. Southeast Asia Microbiome Drugs Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Microbiome Drugs Market Share by Application (2015-2020)
Table 59. Southeast Asia Microbiome Drugs Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Microbiome Drugs Market Share by Country (2015-2020)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Product
Table 64. Pfizer Revenue in Microbiome Drugs Business (2015-2020) (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Second Genome Company Details
Table 67. Second Genome Business Overview
Table 68. Second Genome Product
Table 69. Second Genome Revenue in Microbiome Drugs Business (2015-2020) (US$ Million)
Table 70. Second Genome Recent Development
Table 71. Seres Therapeutics Company Details
Table 72. Seres Therapeutics Business Overview
Table 73. Seres Therapeutics Product
Table 74. Seres Therapeutics Revenue in Microbiome Drugs Business (2015-2020) (US$ Million)
Table 75. Seres Therapeutics Recent Development
Table 76. MaaT Pharma Company Details
Table 77. MaaT Pharma Business Overview
Table 78. MaaT Pharma Product
Table 79. MaaT Pharma Revenue in Microbiome Drugs Business (2015-2020) (US$ Million)
Table 80. MaaT Pharma Recent Development
Table 81. Enterome Bioscience Company Details
Table 82. Enterome Bioscience Business Overview
Table 83. Enterome Bioscience Product
Table 84. Enterome Bioscience Revenue in Microbiome Drugs Business (2015-2020) (US$ Million)
Table 85. Enterome Bioscience Recent Development
Table 86. MicroBiome Therapeutics Company Details
Table 87. MicroBiome Therapeutics Business Overview
Table 88. MicroBiome Therapeutics Product
Table 89. MicroBiome Therapeutics Revenue in Microbiome Drugs Business (2015-2020) (US$ Million)
Table 90. MicroBiome Therapeutics Recent Development
Table 91. Ritter Pharmaceuticals Company Details
Table 92. Ritter Pharmaceuticals Business Overview
Table 93. Ritter Pharmaceuticals Product
Table 94. Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2015-2020) (US$ Million)
Table 95. Ritter Pharmaceuticals Recent Development
Table 96. Rebiotix Business Overview
Table 97. Rebiotix Product
Table 98. Rebiotix Company Details
Table 99. Rebiotix Revenue in Microbiome Drugs Business (2015-2020) (US$ Million)
Table 100. Rebiotix Recent Development
Table 101. OpenBiome Company Details
Table 102. OpenBiome Business Overview
Table 103. OpenBiome Product
Table 104. OpenBiome Revenue in Microbiome Drugs Business (2015-2020) (US$ Million)
Table 105. OpenBiome Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Microbiome Drugs Market Share by Type: 2020 VS 2026
Figure 2. Probiotics Features
Figure 3. Prebiotics Features
Figure 4. Small Molecules Features
Figure 5. Biological Drugs Features
Figure 6. Other Features
Figure 7. Global Microbiome Drugs Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Other Case Studies
Figure 12. Microbiome Drugs Report Years Considered
Figure 13. Global Microbiome Drugs Market Size (US$ Million), YoY Growth 2015-2026
Figure 14. Global Microbiome Drugs Market Share by Regions: 2020 VS 2026
Figure 15. Global Microbiome Drugs Market Share by Regions (2021-2026)
Figure 16. Global Microbiome Drugs Market Share by Players in 2019
Figure 17. Global Top Microbiome Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Drugs as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Microbiome Drugs Revenue in 2019
Figure 19. North America Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. United States Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Canada Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Europe Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Germany Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. France Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. U.K. Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Italy Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Russia Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Nordic Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Rest of Europe Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Asia-Pacific Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. China Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Japan Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. South Korea Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Southeast Asia Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. India Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Australia Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Rest of Asia-Pacific Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Latin America Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Mexico Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Brazil Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Middle East & Africa Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Turkey Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Saudi Arabia Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. UAE Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Rest of Middle East & Africa Microbiome Drugs Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Microbiome Drugs Business (2015-2020)
Figure 47. Second Genome Revenue Growth Rate in Microbiome Drugs Business (2015-2020)
Figure 48. Seres Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2015-2020)
Figure 49. MaaT Pharma Revenue Growth Rate in Microbiome Drugs Business (2015-2020)
Figure 50. Enterome Bioscience Revenue Growth Rate in Microbiome Drugs Business (2015-2020)
Figure 51. MicroBiome Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2015-2020)
Figure 52. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Drugs Business (2015-2020)
Figure 53. Rebiotix Revenue Growth Rate in Microbiome Drugs Business (2015-2020)
Figure 54. OpenBiome Revenue Growth Rate in Microbiome Drugs Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed